These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 9579428)
1. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Rubin SC; Blackwood MA; Bandera C; Behbakht K; Benjamin I; Rebbeck TR; Boyd J Am J Obstet Gynecol; 1998 Apr; 178(4):670-7. PubMed ID: 9579428 [TBL] [Abstract][Full Text] [Related]
2. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy. Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599 [TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families. Sarantaus L; Auranen A; Nevanlinna H Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181 [TBL] [Abstract][Full Text] [Related]
4. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778 [TBL] [Abstract][Full Text] [Related]
5. Hereditary and sporadic ovarian cancer: genetic testing and clinical implications (review). Angioli R; Estape R; Mason M; Penalver M Int J Oncol; 1998 May; 12(5):1029-34. PubMed ID: 9538124 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017 [TBL] [Abstract][Full Text] [Related]
7. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425 [TBL] [Abstract][Full Text] [Related]
8. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759 [TBL] [Abstract][Full Text] [Related]
9. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Malone KE; Daling JR; Neal C; Suter NM; O'Brien C; Cushing-Haugen K; Jonasdottir TJ; Thompson JD; Ostrander EA Cancer; 2000 Mar; 88(6):1393-402. PubMed ID: 10717622 [TBL] [Abstract][Full Text] [Related]
11. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881 [TBL] [Abstract][Full Text] [Related]
12. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2. Frank TS; Deffenbaugh AM; Hulick M; Gumpper K Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259 [TBL] [Abstract][Full Text] [Related]
13. Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Borg A; Isola J; Chen J; Rubio C; Johansson U; Werelius B; Lindblom A Int J Cancer; 2000 Mar; 85(6):796-800. PubMed ID: 10709098 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer. Hodgson SV; Heap E; Cameron J; Ellis D; Mathew CG; Eeles RA; Solomon E; Lewis CM J Med Genet; 1999 May; 36(5):369-73. PubMed ID: 10353781 [TBL] [Abstract][Full Text] [Related]
16. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334 [TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. Bergthorsson JT; Ejlertsen B; Olsen JH; Borg A; Nielsen KV; Barkardottir RB; Klausen S; Mouridsen HT; Winther K; Fenger K; Niebuhr A; Harboe TL; Niebuhr E J Med Genet; 2001 Jun; 38(6):361-8. PubMed ID: 11389159 [TBL] [Abstract][Full Text] [Related]
18. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families. Vaziri SA; Krumroy LM; Rostai M; Casey G Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249 [TBL] [Abstract][Full Text] [Related]
19. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient. Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424 [TBL] [Abstract][Full Text] [Related]
20. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes AM; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A Am J Hum Genet; 1997 May; 60(5):1068-78. PubMed ID: 9150154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]